- Report
- May 2024
- 200 Pages
Global
From €3839EUR$4,150USD£3,229GBP
- Report
- May 2024
- 200 Pages
Global
From €3839EUR$4,150USD£3,229GBP
- Report
- May 2024
- 200 Pages
Global
From €3839EUR$4,150USD£3,229GBP
- Report
- March 2024
- 200 Pages
Global
From €3839EUR$4,150USD£3,229GBP
- Report
- January 2024
- 200 Pages
Global
From €3839EUR$4,150USD£3,229GBP
- Report
- January 2024
- 200 Pages
Global
From €3839EUR$4,150USD£3,229GBP
- Report
- January 2024
- 200 Pages
Global
From €3839EUR$4,150USD£3,229GBP
- Report
- October 2023
- 145 Pages
Global
From €2914EUR$3,150USD£2,451GBP
- Report
- August 2023
- 145 Pages
Global
From €2914EUR$3,150USD£2,451GBP
- Report
- August 2023
- 145 Pages
Global
From €2914EUR$3,150USD£2,451GBP
- Report
- July 2023
- 145 Pages
Global
From €2914EUR$3,150USD£2,451GBP
- Report
- January 2024
- 141 Pages
Global
From €3932EUR$4,250USD£3,306GBP
- Report
- April 2022
- 120 Pages
Global
From €4117EUR$4,450USD£3,462GBP
- Report
- July 2021
- 112 Pages
Global
From €4117EUR$4,450USD£3,462GBP
- Report
- March 2023
- 211 Pages
Global
From €4117EUR$4,450USD£3,462GBP
- Report
- June 2024
- 86 Pages
From €3192EUR$3,450USD£2,684GBP
- Report
- March 2024
- 150 Pages
Global
From €4117EUR$4,450USD£3,462GBP
- Report
- February 2024
- 163 Pages
Europe
From €3192EUR$3,450USD£2,684GBP
- Report
- February 2024
- 161 Pages
Asia Pacific
From €3192EUR$3,450USD£2,684GBP
- Report
- February 2024
- 61 Pages
From €3192EUR$3,450USD£2,684GBP

The Genetic Disease market is a subset of the Genomics market that focuses on the diagnosis, treatment, and prevention of genetic diseases. It is a rapidly growing field, driven by advances in technology and the increasing availability of genetic testing. Companies in this market are developing new treatments and therapies for genetic diseases, as well as diagnostic tests and tools to identify and monitor them. They are also researching ways to prevent genetic diseases from occurring in the first place.
Companies in the Genetic Disease market include Illumina, Thermo Fisher Scientific, BGI, Genomic Health, and Invitae. These companies are developing innovative products and services to help diagnose, treat, and prevent genetic diseases. They are also investing in research and development to further advance the field. Show Less Read more